Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR
- Status
- UNKNOWN
- Phase
- PHASE2
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
- Status
- COMPLETED
- Phase
- N/A
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Sym004 Versus TAS-102 in Patients With mCRC
- Status
- WITHDRAWN
- Phase
- PHASE3